This diagnostic comparison chart displays two Fourier-transform infrared (FTIR) spectra used in pharmaceutical analysis. Graph (a) represents the spectrum of pure Felodipine (FL), a dihydropyridine calcium channel blocker, while graph (b) shows the spectrum of Spherical agglomerates FI-2, a formulation incorporating Inutec SP1 to enhance drug dissolution. Both plots utilize the vertical axis for percent transmittance (%T) and the horizontal axis for wavenumber (cm⁻¹), ranging from 4000 to 500 cm⁻¹. Key diagnostic peaks for Felodipine are visible in both spectra, including a sharp peak near 3371.57 cm⁻¹ (N-H stretching of secondary amine), aromatic C-H stretching around 3068.75 cm⁻¹, and a prominent C=O carbonyl stretching peak at 1689.64 cm⁻¹. The fingerprint region (below 1500 cm⁻¹) exhibits characteristic C-Cl stretching. The high degree of similarity between spectra (a) and (b) indicates that the chemical integrity of the active pharmaceutical ingredient is maintained during the spherical crystallization process, with no significant covalent interactions or degradation observed between the drug and the excipients.

This medical visual combines clinical intraoral photographs with a conceptual diagram to illustrate drug-induced gingival overgrowth (DIGO). The central photographs compare the gingival manifestations of two specific pharmacological agents: Nifedipine (a calcium channel blocker) and Dilantin (Phenytoin, an anticonvulsant). The Nifedipine clinical image displays erythematous, swollen gingival margins with moderate hyperplasia. The Dilantin image demonstrates more severe, generalized gingival overgrowth characterized by bulbous interdental papillae and extensive coverage of the clinical crowns by thickened, lobulated gingival tissue. Surrounding these images is a pathophysiological flow diagram explaining the mechanism of extracellular matrix (ECM) disruption. Key educational concepts mapped include the drug-induced blockade of calcium-permeable channels (such as TRPV4), the inhibition of calcium-dependent ECM remodeling, and the selection of pro-fibrotic fibroblast lineages. The diagram highlights how pro-inflammatory signaling synergizes with these drug effects to disturb the homeostatic balance of collagen synthesis and degradation in periodontal tissues, leading to the observed pathological tissue enlargement.

This diagnostic comparison chart displays two sets of contour plots illustrating the sensitivity of a cost function (HV+Ca) to pairwise perturbations of ion channel conductances (λNa, λCaL, λKr, λK1). The data represents electrophysiological inversion results from a cardiac Micro-Physiological System (MPS). The left panel corresponds to the effects of 100 nM Verapamil, known to block both L-type calcium (ICaL) and rapid delayed rectifier potassium (IKr) currents. The right panel represents 10 nM Cisapride, a selective IKr blocker. Each 3x2 grid shows different parameter pairings; color intensity represents the cost function value, where darker blue signifies higher values and yellow indicates a minimum (optimal fit). In the Cisapride group, the λKr vs. λCaL plot displays dense, vertical contour lines, indicating high sensitivity of the model specifically to perturbations in the IKr current. This visualization is used in cardiac pharmacology to identify drug-induced channel blockades by comparing experimental voltage and calcium transients with mathematical cell models.

This diagnostic comparison chart displays two sets of contour plots illustrating the sensitivity of a cost function (HV+Ca) to pairwise perturbations of ion channel conductances (λNa, λCaL, λKr, λK1). The data represents electrophysiological inversion results from a cardiac Micro-Physiological System (MPS). The left panel corresponds to the effects of 100 nM Verapamil, known to block both L-type calcium (ICaL) and rapid delayed rectifier potassium (IKr) currents. The right panel represents 10 nM Cisapride, a selective IKr blocker. Each 3x2 grid shows different parameter pairings; color intensity represents the cost function value, where darker blue signifies higher values and yellow indicates a minimum (optimal fit). In the Cisapride group, the λKr vs. λCaL plot displays dense, vertical contour lines, indicating high sensitivity of the model specifically to perturbations in the IKr current. This visualization is used in cardiac pharmacology to identify drug-induced channel blockades by comparing experimental voltage and calcium transients with mathematical cell models.

This composite educational image illustrates the in vivo biodistribution of [13N]nifedipine, a radiolabeled calcium channel blocker, in a healthy rat model using preclinical PET/CT imaging. Panels A, B, and C present Maximum Intensity Projections (MIP) at sequential 10-minute intervals (0-30 min post-injection). The initial phase (0-10 min) demonstrates significant tracer accumulation in the brain (Br), carotid artery (Ca), heart (He), and liver (Li), visualized as high-intensity hotspots. Panel D provides a line graph showing quantitative mean activity (Bq/voxel) over time for the blood, heart, liver, and brain. The data indicates that the brain achieves the highest peak activity (~0.8 Bq/voxel) followed by a gradual decrease, while the heart shows early peak uptake and rapid clearance. The liver maintains a steady activity level (~0.6 Bq/voxel), reflecting hepatic metabolism. This study demonstrates the utility of nitrogen-13 labeling for investigating calcium channel function and pharmacokinetics in cardiac and neurological research without altering the drug's chemical structure.

This diagnostic graphic presents a multi-panel set of mass spectrometry chromatograms labeled K through R, used for clinical biochemical analysis of calcium channel blockers (CCBs) in human plasma. Each panel illustrates a signal plot with 'Time (min)' on the x-axis (ranging from 0 to 8 minutes) and 'Relative Abundance' on the y-axis (scaled 0 to 100). The chromatograms represent blank plasma samples used to assess selectivity and carryover effects during the validation of an ultra-HPLC-MS/MS method. Key features include normalization levels (NL) indicated in the top left of each panel, ranging from approximately 1.00 x 10^2 to 2.22 x 10^2. The plots demonstrate baseline noise and the absence of significant interfering peaks at the retention times for analytes such as amlodipine, nifedipine, and nimodipine. Panels M through R specifically represent blank samples analyzed after high-concentration quality control (HQC) samples to verify minimal carryover, which is critical for ensuring the accuracy and precision of quantitative toxicological or pharmacological assays in medical diagnostics.

This figure presents pharmaceutical characterization data for verapamil hydrochloride (VRP), a calcium channel blocker, comparing a reference sample with samples recrystallized from acetone and isopropanol. (a) X-ray Diffraction (XRD) patterns: The three diffractograms show identical peak positions and relative intensities across the 2-theta range (approx. 5–60 degrees), confirming that the recrystallization solvents did not alter the crystalline habit or unit cell of the drug. (b) Differential Scanning Calorimetry (DSC) curves: The thermal analysis plots depict endothermic fusion peaks (melting points) around 146 °C. The VRP reference shows a sharp, narrow endotherm corresponding to a high purity of 99.15%. The recrystallized samples demonstrate broader fusion peaks and lower purity percentages (96.19% for acetone and 94.18% for isopropanol), indicating that recrystallization introduced minor impurities that widened the melting range. This material is used to teach concepts of drug stability, polymorphism, and purity assessment in pharmaceutical sciences.

Clinical photograph of the face focusing on pilosebaceous units in the central facial region. This high-magnification close-up reveals multiple open comedones with keratin plugs, several closed comedones, and inflammatory papules and pustules. Deeper nodules or cystic lesions are present, producing a nodular aspect with surrounding erythema and oily, sebaceous-active skin. The distribution is characteristic of acne vulgaris, predominantly involving the cheeks and perioral areas. The image captures a spectrum from noninflammatory comedones to inflammatory and nodulocystic components, reflecting follicular obstruction and sebaceous gland hyperactivity. Clinically, this pattern is associated with acne severity that can lead to scarring if inadequately treated. Differential considerations include folliculitis and rosacea (rosacea less likely given comedones), sebaceous hyperplasia, and keratosis pilaris with follicular involvement. This photo is valuable for dermatology education, patient counseling, and research on acne pathophysiology and treatment response. Potential applications encompass training in recognition of open and closed comedones, assessment of inflammatory burden, and monitoring response to topical therapies (retinoids, benzoyl peroxide) and systemic options (antibiotics, isotretinoin). Additional observations include follicular plugging, surface scale, microcrusting, post-inflammatory hyperpigmentation, and signs of early scarring potential. The close view supports standardized lesion counting and severity grading for clinical trials and educational demonstrations, as well as patient-specific treatment planning and outcome tracking.

Clinical photograph of adult facial skin showing acne vulgaris. Modality: color digital photography; close-up frontal view of left cheek and perioral region. The skin shows numerous small inflammatory papules and closed comedones within erythematous background. Surface shows rough texture, post-inflammatory hyperpigmentation; no visible pustules or nodules beyond papules; sebaceous prominence; mild focal scarring. The distribution is predominantly in the central to lower cheek and perioral zones; symmetric involvement is suspected though lateralization not certain in this single frame. The visual features correspond to acne vulgaris, predominantly non-inflammatory comedones and mild inflammatory papules; differential includes rosacea (erythema with flushing and telangiectasia), folliculitis, perioral dermatitis. Clinically significant due to risk of scarring if untreated; management typically includes topical retinoids (tretinoin, adapalene), benzoyl peroxide, salicylic acid, topical/oral antibiotics, hormonal therapy in women; isotretinoin in severe cases. This image provides educational reference for adult-onset facial acne assessment, severity grading (milDer-type with comedones and papules), and therapy planning. Notable clinical context: identify pilosebaceous unit involvement, comedone formation, and post-inflammatory hyperpigmentation. Educational value includes recognizing lesion morphology, distinguishing acne from similar mimics, and selecting appropriate imaging-assisted documentation for follow-up, patient education, and clinical trials evaluating novel anti-acne therapies. This supports standardized severity assessment and treatment planning.

A series of clinical photographs illustrating the treatment of acne vulgaris categorized by severity. The top row (A, B, C) shows 'before' images, and the bottom row (D, E, F) shows 'after' images following a 2-month combined therapy. Panels A and D represent a mild case, showing a reduction in small, scattered inflammatory papules and comedones. Panels B and E depict a moderate case, showing a significant decrease in the density of erythematous papules and pustules on the cheek. Panels C and F represent a severe case, demonstrating an improvement in widespread inflammatory lesions, nodules, and post-inflammatory hyperpigmentation. Overall, the post-treatment images (D-F) show marked improvement in skin texture, a reduction in total lesion count, and a decrease in associated erythema across different grades of acne severity.

Clinical photography of the left facial skin demonstrates an acneiform eruption involving the left cheek and mandible. Modality: Digital clinical photography; technique: standard unpolarized light, frontal-left oblique perspective capturing the dermal and pilosebaceous units. Anatomical location includes facial skin in the dermal and epidermal compartments with emphasis on the zygomatic and mandibular regions. Visual features: scattered erythematous papules and pustules of varying size scattered across the malar region and jawline, with some small open comedones. Adjacent areas show macular hyperpigmentation consistent with post-inflammatory hyperpigmentation. Skin texture is uneven with mild edema, and there may be shallow scarring or atrophic changes in chronic lesions. Pathophysiology: acne vulgaris affecting pilosebaceous units; inflammation ranges from papular to pustular, with follicular plugging producing comedones. Clinical significance: typical adolescent-to-young-adult acne; differential includes rosacea (erythematous papules, flushing), folliculitis, and keratosis pilaris; imaging not used for diagnosis but this photo is instrumental for clinical assessment and treatment planning. Potential clinical use: educational dermatology resource, baseline documentation for therapy response (topical retinoids, benzoyl peroxide, antibiotics, hormonal therapy as indicated), patient counseling, research on acne severity scoring. This image may aid clarity for students learning acne morphology, helps distinguish inflammatory papules from nodules, and supports standardized lesion counting and grading scales used in clinical trials.